Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice

Laboratory Investigation

Volumn 83, Issue 4, 2003, Pages 561-570

  Iwaki, Takayuki ^a   Sugimura, Motoi ^a,c   Nishihira, Jun ^b   Matsuura, Toshiki ^a   Kobayashi, Takao ^a   Kanayama, Naohiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIGEN; BCG VACCINE; COMPLEMENTARY DNA; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN 3T3; CELL STRAIN COS7; CONTROLLED STUDY; CORRELATION ANALYSIS; COSMID VECTOR; CYTOKINE PRODUCTION; GENE; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER INJURY; MACROPHAGE; MIF GENE; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SURVIVAL RATE; VIRUS INFECTION;

EID: 0037392713     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000062857.26210.EF     Document Type: Article

References (42)

1. Abe R, Shimizu T, Ohkawara A, and Nishihira J (2000). Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochem Biophys Acta 1500:1-9.
2. Arcuri F, del Vecchio MT, de Santi MM, Lalinga AV, Pallini V, Bini L, Bartolommei S, Parigi S, and Cintorino M (1999). Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localization. Prostate 39:159-165.
3. Austyn JM and Gordon S (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805-815.
4. Bernal W and Wendon J (1999). Acute liver failure: Clinical features and management. Eur J Gastroenterol Hepatol 9:977-984.
5. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, and Bucala R (1993). MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759.
6. Bloom BR and Bennett B (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82.
7. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, and David JR (1999). Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341-346.
8. Bucala R (1996). MIF re-discovered: Pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 7:19-24.
9. Bucala R (2000). Signal transduction. A most interesting factor. Nature 408:146-147.
10. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, and Bucala R (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71.
11. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, and Glauser MP (2000). Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6:164-170.
12. David JR (1966). Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72-77.
13. Ferluga J (1981). Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG). Am J Pathol 105:82-90.
14. Ferluga J and Allison AC (1978). Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 2:610-611.
15. Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, Ooi A, Mai M, and Matsushima K (1995). Preparation of specific antibodies against murine IL-lra and the establishment of IL-lra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 58:90-98.
16. Honma N, Koseki H, Akasaka T, Nakayama T, Taniguchi M, Serizawa I, Akahori H, Osawa M, and Mikayama T (2000). Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100: 84-90.
17. Kanegae Y, Makimura M, and Saito I (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157-166.
18. Kiwaki K, Kanegae Y, Saito I, Komaki S, Nakamura K, Miyazaki JI, Endo F, and Matsuda I (1996). Correction of ornithine transcarbamylase deficiency in adult spf (ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter. Hum Gene Ther 7:821-830.
19. Kleemann R, Hausser A, Geiger, G. Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, and Bernhagen J (2000). Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216.
20. Kobayashi S, Nishihira J, Watanabe S, and Todo S (1999). Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with Bacille Calmette-Guerin and lipopolysaccharide. Hepatology 29:1752-1759.
21. Leech M, Metz C, Bucala R, and Morand EF (2000). Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 43:827-833.
22. Liu P, Ohnishi H, Moriwaki H, and Muto Y (1990). Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice. Gastroenterol Jpn 25:339-342.
23. Matsui K, Yoshimoto T, Tsutsui H, Hyodo Y, Hayashi N, Hiroishi K, Kawada N, Okamura H, Nakanishi K, and Higashino K (1997). Propioni bacterium acnes treatment diminishes CD4+ NK1.1 + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 159:97-106.
24. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, and Bucala R (1995). Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154:3863-3870.
25. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, and Saito I (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324.
26. Mizoguchi Y, Sakagami Y, Kuboi H, Kobayashi K, and Yano I (1988). Effects of the polysaccharide chain of lipopolysaccharide in an experimental massive hepatic cell necrosis model. Biochem Biophys Res Commun 155:1305-1310.
27. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, and Mukai M (2000). Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: Elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397-403.
28. Nishihira J (2000). Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth. J Interferon Cytokine Res 20:751-762.
29. Nishihira J, Koyama Y, and Mizue Y (1998). Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10:199-205.
30. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, and Hattori K (1996). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91.
31. Ostapowicz G and Lee WM (2000). Acute hepatic failure: A Western perspective. J Gastroenterol Hepatol 15:480-488.
32. Paralkar V and Wistow G (1994). Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19:48-51.
33. Peeters MJ, Patijn GA, Liebert A, Meuse L, and Kay MA (1996). Adenovirus-mediated hepatic gene transfer in mice: Comparison of intravascular and biliary administration. Hum Gene Ther 7:1693-1699.
34. Sakai M, Nishihira J, Hibiya Y, Koyama Y, and Nishi S (1994). Glutathione binding rat liver 13K protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int 33:439-446.
35. Shands JW Jr and Senterfitt VC (1972). Endotoxin-induced hepatic damage in BCG-infected mice. Am J Pathol 67:23-40.
36. Simpson KJ (1999). Cytokines, for better or worse? Eur J Gastroenterol Hepatol 11:957-966.
37. Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T, Habu S, and Nishimura T (1996). A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int Immunol 8:569-576.
38. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamaguchi K, and Hayashi N (2000). Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterol 95:2040-2046.
39. Tsuji H, Harada A, Mukaida N, Nakanuma Y, Bluethmann H, Kaneko S, Yamakawa K, Nakamura SI, Kobayashi KI, and Matsushima K (1997). Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect Immun 65:1892-1898.
40. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, and Nakanishi K (1997). IL-18 accounts for both TNF-alpha- and fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159:3961-1967.
41. Wada S, Fujimoto S, Mizue Y, and Nishihira J (1997). Macrophage migration inhibitory factor in the human ovary: Presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int 41:805-814.
42. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, and David JR (1989). Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 86:7522-7526.